Farther Finance Advisors LLC Grows Holdings in Synopsys, Inc. $SNPS

Farther Finance Advisors LLC raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 130.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,339 shares of the semiconductor company’s stock after purchasing an additional 2,460 shares during the quarter. Farther Finance Advisors LLC’s holdings in Synopsys were worth $2,141,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in SNPS. Vanguard Group Inc. lifted its holdings in Synopsys by 1.6% during the 2nd quarter. Vanguard Group Inc. now owns 15,060,784 shares of the semiconductor company’s stock valued at $7,721,363,000 after buying an additional 231,014 shares in the last quarter. State Street Corp increased its position in shares of Synopsys by 1.2% during the second quarter. State Street Corp now owns 7,266,446 shares of the semiconductor company’s stock worth $3,725,362,000 after acquiring an additional 85,662 shares during the period. Geode Capital Management LLC raised its stake in shares of Synopsys by 1.5% during the second quarter. Geode Capital Management LLC now owns 3,545,892 shares of the semiconductor company’s stock valued at $1,810,214,000 after acquiring an additional 51,043 shares in the last quarter. Ameriprise Financial Inc. boosted its holdings in shares of Synopsys by 29.1% in the second quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock valued at $1,333,095,000 after purchasing an additional 585,494 shares during the period. Finally, Alliancebernstein L.P. grew its stake in Synopsys by 10.9% in the second quarter. Alliancebernstein L.P. now owns 1,913,001 shares of the semiconductor company’s stock worth $980,757,000 after purchasing an additional 187,790 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

SNPS has been the subject of a number of research analyst reports. Needham & Company LLC lifted their target price on Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Mizuho lowered their price objective on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a research note on Thursday, September 11th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and cut their target price for the company from $525.00 to $500.00 in a research report on Monday, December 8th. BNP Paribas started coverage on shares of Synopsys in a report on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 price target for the company. Finally, Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Eleven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $562.13.

Insider Transactions at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares in the company, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.62% of the stock is owned by corporate insiders.

Synopsys Stock Up 0.3%

Shares of Synopsys stock opened at $477.14 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The company has a market cap of $91.29 billion, a P/E ratio of 59.72, a PEG ratio of 3.96 and a beta of 1.16. The firm’s 50 day moving average price is $437.58 and its 200-day moving average price is $503.61. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73.

Synopsys (NASDAQ:SNPS) last announced its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.11. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. Synopsys’s revenue was up 37.8% compared to the same quarter last year. During the same period last year, the firm earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, sell-side analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

More Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.